Rethinking and redefining the definitions and how we measure availability and affordability of medicines and technologies for non-communicable diseases by David Beran, Margaret Ewen, Christophe Perrin, Cécile Macé, Stephane Besancon, Molly Lepeska, Céline Mettraux, Andrew Gilmoor, Marina Giachino, Joanna Laurson-Doube, Janeth Tenorio Mucha, Rosalind Turkie

Get full text